Delivery Order SPE2DR25D9756-SPE2DR26FKPH2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The award, issued on January 7, 2026, with an ultimate completion date of January 29, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor's ability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The delivery order, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, was awarded on a firm fixed-price basis without set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $2,518.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The contract, issued on January 23, 2026, with an ultimate completion date of February 13, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating that DMS Pharmaceutical Group competed against other vendors in an...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The contract, awarded on December 17, 2025, with an ultimate completion date of January 9, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The contract, designated as a firm fixed-price delivery order with an ultimate completion date of February 18, 2026, was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a $15,108.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The delivery order, issued on January 14, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This award...
- The Defense Logistics Agency awarded a $11,135.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The contract, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order falls under DMS...
- The Defense Logistics Agency awarded a $3,147.70 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (Yellow Fever vaccine) in single-dose vials. The delivery order, issued on January 8, 2026, with an ultimate completion date of January 30, 2026, operates under a firm fixed-price structure with no set-aside designation. This award represents a tactical procurement executed through DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,518.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The award was made on December 29, 2025, with an ultimate completion date of January 21, 2026, under a firm fixed-price contract structure with no set-aside designation. This delivery order represents one of numerous purchases issued to...
- SPE2DR25D9756Indefinite Delivery Contract
- SPE2DR25D9756-SPE2DR26FKPH2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The award was issued on January 28, 2026, with an ultimate completion date of February 19, 2026, under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status to compete effectively in government procurement while maintaining consistent performance across multiple therapeutic categories. The company's primary IDC with the Defense Logistics Agency, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. This contract structure enables the company to deliver an extensive portfolio of branded and generic prescription medications, biologics, vaccines, and medical consumables to support the recurring medical supply needs of the military healthcare system globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/27/26 |